Search research articles
Contact Us
Filters
Showing results (91-100 of 135) with videos related to
Page
of 14
Sort By:
ACS Central Science
|
March 4, 2020
Competitive Metabolite Profiling of Natural Products Reveals Subunit Specific Inhibitors of the 20S Proteasome
Atul Pawar, Michael Basler, Heike Goebel, et al.
British Journal of Pharmacology
|
October 17, 2017
Amelioration of autoimmunity with an inhibitor selectively targeting all active centres of the immunoproteasome
Michael Basler, Elmer Maurits, Gerjan de Bruin, et al.
Molecular Immunology
|
December 4, 2012
Endosomal trafficking of open Major Histocompatibility Class I conformers--implications for presentation of endocytosed antigens
Hana Mahmutefendić, Gordana Blagojević Zagorac, Maja Ilić Tomaš, et al.
Journal of Leukocyte Biology
|
August 19, 2007
Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO
Petra Krause, Eva Singer, Paula I Darley, et al.
Journal of Cell Science
|
July 17, 2012
The proteomic analysis of endogenous FAT10 substrates identifies p62/SQSTM1 as a substrate of FAT10ylation
Annette Aichem, Birte Kalveram, Valentina Spinnenhirn, et al.
Journal of Cell Science
|
June 18, 2020
FAT10 localises in dendritic cell aggresome-like induced structures and contributes to their disassembly
Richard Schregle, Stefanie Mueller, Daniel F Legler, et al.
Journal of Drug Targeting
|
July 23, 2009
Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response
Stefan Fischer, Eva Schlosser, Marc Mueller, et al.
EMBO Molecular Medicine
|
January 9, 2014
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
Michael Basler, Sarah Mundt, Tony Muchamuel, et al.
The Journal of Biological Chemistry
|
May 19, 2006
The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10
Gunter Schmidtke, Birte Kalveram, Elvira Weber, et al.
Blood
|
November 1, 2003
CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2
Elke Scandella, Ying Men, Daniel F Legler, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 135) with videos related to
Sort By:
Page
of 14
ACS Central Science
|
March 4, 2020
Competitive Metabolite Profiling of Natural Products Reveals Subunit Specific Inhibitors of the 20S Proteasome
Atul Pawar, Michael Basler, Heike Goebel, et al.
British Journal of Pharmacology
|
October 17, 2017
Amelioration of autoimmunity with an inhibitor selectively targeting all active centres of the immunoproteasome
Michael Basler, Elmer Maurits, Gerjan de Bruin, et al.
Molecular Immunology
|
December 4, 2012
Endosomal trafficking of open Major Histocompatibility Class I conformers--implications for presentation of endocytosed antigens
Hana Mahmutefendić, Gordana Blagojević Zagorac, Maja Ilić Tomaš, et al.
Journal of Leukocyte Biology
|
August 19, 2007
Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO
Petra Krause, Eva Singer, Paula I Darley, et al.
Journal of Cell Science
|
July 17, 2012
The proteomic analysis of endogenous FAT10 substrates identifies p62/SQSTM1 as a substrate of FAT10ylation
Annette Aichem, Birte Kalveram, Valentina Spinnenhirn, et al.
Journal of Cell Science
|
June 18, 2020
FAT10 localises in dendritic cell aggresome-like induced structures and contributes to their disassembly
Richard Schregle, Stefanie Mueller, Daniel F Legler, et al.
Journal of Drug Targeting
|
July 23, 2009
Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response
Stefan Fischer, Eva Schlosser, Marc Mueller, et al.
EMBO Molecular Medicine
|
January 9, 2014
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
Michael Basler, Sarah Mundt, Tony Muchamuel, et al.
The Journal of Biological Chemistry
|
May 19, 2006
The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10
Gunter Schmidtke, Birte Kalveram, Elvira Weber, et al.
Blood
|
November 1, 2003
CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2
Elke Scandella, Ying Men, Daniel F Legler, et al.
Page
of 14